CohBar Investor Relations Material

CohBar, Inc. is a clinical stage biotechnology company based in California that focuses on the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The Company's platform technology involves improving cellular metabolism to enhance healthy biological aging through encapsulation of mitochondria within multifunctional liposomes. Cohbar's sales channels are through direct sales and through distributors who are licensed to market its products both domestically and internationally.